Press releases
- dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group
- dsm-firmenich issues €800 million long-term bond
- DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST
- dsm-firmenich announces sale of yeast extract business to Lesaffre
- dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty
- dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
- Methane-reducing feed ingredient Bovaer® ready for US market launch
- dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
- Share repurchase program to cover share plans completed
- dsm-firmenich Q1 2024 trading update
More ▼
Key statistics
As of last trade DSM-Firmenich AG (DSFIY:QXE) traded at 12.27, -1.45% below its 52-week high of 12.45, set on Jul 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.10 |
---|---|
High | 12.29 |
Low | 12.02 |
Bid | -- |
Offer | -- |
Previous close | 12.20 |
Average volume | 36.11k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.2715 USD |
---|---|
Annual div yield (ADY) | 2.23% |
Div ex-date | May 09 2024 |
Div pay-date | May 23 2024 |
Data delayed at least 15 minutes, as of Jul 22 2024 17:45 BST.
More ▼